Cargando…

Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked

Prions are lethal infectious agents thought to consist of multi-chain forms (PrP(Sc)) of misfolded cellular prion protein (PrP(C)). Prion propagation proceeds in two distinct mechanistic phases: an exponential phase 1, which rapidly reaches a fixed level of infectivity irrespective of PrP(C) express...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandberg, Malin K., Al-Doujaily, Huda, Sharps, Bernadette, De Oliveira, Michael Wiggins, Schmidt, Christian, Richard-Londt, Angela, Lyall, Sarah, Linehan, Jacqueline M., Brandner, Sebastian, Wadsworth, Jonathan D. F., Clarke, Anthony R., Collinge, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104459/
https://www.ncbi.nlm.nih.gov/pubmed/25005024
http://dx.doi.org/10.1038/ncomms5347
_version_ 1782327262474928128
author Sandberg, Malin K.
Al-Doujaily, Huda
Sharps, Bernadette
De Oliveira, Michael Wiggins
Schmidt, Christian
Richard-Londt, Angela
Lyall, Sarah
Linehan, Jacqueline M.
Brandner, Sebastian
Wadsworth, Jonathan D. F.
Clarke, Anthony R.
Collinge, John
author_facet Sandberg, Malin K.
Al-Doujaily, Huda
Sharps, Bernadette
De Oliveira, Michael Wiggins
Schmidt, Christian
Richard-Londt, Angela
Lyall, Sarah
Linehan, Jacqueline M.
Brandner, Sebastian
Wadsworth, Jonathan D. F.
Clarke, Anthony R.
Collinge, John
author_sort Sandberg, Malin K.
collection PubMed
description Prions are lethal infectious agents thought to consist of multi-chain forms (PrP(Sc)) of misfolded cellular prion protein (PrP(C)). Prion propagation proceeds in two distinct mechanistic phases: an exponential phase 1, which rapidly reaches a fixed level of infectivity irrespective of PrP(C) expression level, and a plateau (phase 2), which continues until clinical onset with duration inversely proportional to PrP(C) expression level. We hypothesized that neurotoxicity relates to distinct neurotoxic species produced following a pathway switch when prion levels saturate. Here we show a linear increase of proteinase K-sensitive PrP isoforms distinct from classical PrP(Sc) at a rate proportional to PrP(C) concentration, commencing at the phase transition and rising until clinical onset. The unaltered level of total PrP during phase 1, when prion infectivity increases a million-fold, indicates that prions comprise a small minority of total PrP. This is consistent with PrP(C) concentration not being rate limiting to exponential prion propagation and neurotoxicity relating to critical concentrations of alternate PrP isoforms whose production is PrP(C) concentration dependent.
format Online
Article
Text
id pubmed-4104459
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-41044592014-07-22 Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked Sandberg, Malin K. Al-Doujaily, Huda Sharps, Bernadette De Oliveira, Michael Wiggins Schmidt, Christian Richard-Londt, Angela Lyall, Sarah Linehan, Jacqueline M. Brandner, Sebastian Wadsworth, Jonathan D. F. Clarke, Anthony R. Collinge, John Nat Commun Article Prions are lethal infectious agents thought to consist of multi-chain forms (PrP(Sc)) of misfolded cellular prion protein (PrP(C)). Prion propagation proceeds in two distinct mechanistic phases: an exponential phase 1, which rapidly reaches a fixed level of infectivity irrespective of PrP(C) expression level, and a plateau (phase 2), which continues until clinical onset with duration inversely proportional to PrP(C) expression level. We hypothesized that neurotoxicity relates to distinct neurotoxic species produced following a pathway switch when prion levels saturate. Here we show a linear increase of proteinase K-sensitive PrP isoforms distinct from classical PrP(Sc) at a rate proportional to PrP(C) concentration, commencing at the phase transition and rising until clinical onset. The unaltered level of total PrP during phase 1, when prion infectivity increases a million-fold, indicates that prions comprise a small minority of total PrP. This is consistent with PrP(C) concentration not being rate limiting to exponential prion propagation and neurotoxicity relating to critical concentrations of alternate PrP isoforms whose production is PrP(C) concentration dependent. Nature Pub. Group 2014-07-09 /pmc/articles/PMC4104459/ /pubmed/25005024 http://dx.doi.org/10.1038/ncomms5347 Text en Copyright © 2014, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Sandberg, Malin K.
Al-Doujaily, Huda
Sharps, Bernadette
De Oliveira, Michael Wiggins
Schmidt, Christian
Richard-Londt, Angela
Lyall, Sarah
Linehan, Jacqueline M.
Brandner, Sebastian
Wadsworth, Jonathan D. F.
Clarke, Anthony R.
Collinge, John
Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
title Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
title_full Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
title_fullStr Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
title_full_unstemmed Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
title_short Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
title_sort prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104459/
https://www.ncbi.nlm.nih.gov/pubmed/25005024
http://dx.doi.org/10.1038/ncomms5347
work_keys_str_mv AT sandbergmalink prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT aldoujailyhuda prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT sharpsbernadette prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT deoliveiramichaelwiggins prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT schmidtchristian prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT richardlondtangela prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT lyallsarah prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT linehanjacquelinem prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT brandnersebastian prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT wadsworthjonathandf prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT clarkeanthonyr prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked
AT collingejohn prionneuropathologyfollowstheaccumulationofalternateprionproteinisoformsafterinfectivetitrehaspeaked